Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$40.86 - $57.65 $286,020 - $403,550
-7,000 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$37.38 - $49.47 $186,900 - $247,350
5,000 Added 250.0%
7,000 $292,000
Q2 2019

Aug 13, 2019

BUY
$39.79 - $67.01 $79,580 - $134,020
2,000 New
2,000 $88,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Btg Pactual Global Asset Management LTD Portfolio

Follow Btg Pactual Global Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.